AU1521997A - Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus - Google Patents

Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus

Info

Publication number
AU1521997A
AU1521997A AU15219/97A AU1521997A AU1521997A AU 1521997 A AU1521997 A AU 1521997A AU 15219/97 A AU15219/97 A AU 15219/97A AU 1521997 A AU1521997 A AU 1521997A AU 1521997 A AU1521997 A AU 1521997A
Authority
AU
Australia
Prior art keywords
kaposi
sarcoma
antibodies
screening tests
associated herpesvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15219/97A
Inventor
Elizabeth Grogan
Lee Heston
Su-Fang Lin
George Miller
Michael Rigsby
Ren Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU1521997A publication Critical patent/AU1521997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16411Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16422New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU15219/97A 1995-12-27 1996-12-26 Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus Abandoned AU1521997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US926795P 1995-12-27 1995-12-27
US009267 1995-12-27
PCT/US1996/020839 WO1997024057A2 (en) 1995-12-27 1996-12-26 Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus

Publications (1)

Publication Number Publication Date
AU1521997A true AU1521997A (en) 1997-07-28

Family

ID=21736609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15219/97A Abandoned AU1521997A (en) 1995-12-27 1996-12-26 Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus

Country Status (2)

Country Link
AU (1) AU1521997A (en)
WO (1) WO1997024057A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932066B2 (en) 1994-08-18 2011-04-26 The Trustees Of Columbia University In The City Of New York Unique associated kaposi's sarcoma virus sequences and uses thereof
US6348586B1 (en) 1996-07-25 2002-02-19 The Trustees Of Columbia University In The City Of New York Unique associated Kaposi's sarcoma virus sequences and uses thereof
CA2261164A1 (en) * 1996-07-25 1998-02-05 The Trustees Of Columbia University In The City Of New York Unique associated kaposi's sarcoma virus sequences and uses thereof
AU4095899A (en) * 1998-05-26 1999-12-13 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions for the detection of human herpesvirus
US6669939B1 (en) 1998-05-29 2003-12-30 Biotrin International Properties Limited (Poly)peptides which represent the epitopes of the human herpes virus type 8
FR2782519A1 (en) * 1998-08-24 2000-02-25 Bio Merieux New polypeptide useful as an immunoassay reagent for specific detection of antibodies to human herpes virus type 8 (HHV8) comprises part of the C-terminal sequence of the ORF 65 capsid protein of HHV8
US8951723B2 (en) 2009-02-12 2015-02-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Serological screening for HHV-8 infection using antigen mixtures
WO2022026537A1 (en) * 2020-07-28 2022-02-03 The Trustees Of Princeton University Method for detection and quantitative monitoring of infections with herpesviruses

Also Published As

Publication number Publication date
WO1997024057A2 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
AU1866895A (en) Human monoclonal antibodies to herpes simplex virus and methods therefor
EP0759071A4 (en) Wt1 monoclonal antibodies and methods of use therefor
PL329930A1 (en) Antigens of human lymphocytes b and related reagents
IL122404A0 (en) High affinity human monoclonal antibodies specific for rsv f-protein
ZA965078B (en) Catalyst and process for the preparation of hydrocarbons
EP0777497A4 (en) Human neutralizing monoclonal antibodies to human immunodeficiency virus
EP0797951A4 (en) Blood specimen collector
SG63679A1 (en) Disposable diaper
TW466944U (en) Disposable diaper
TW341116U (en) Disposable diaper
AU1460195A (en) Antibodies to egf receptor and their antitumour effect
EP0724870A3 (en) Disposable diaper
TW380421U (en) Disposable diaper
TW538744U (en) Disposable diaper
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
ZA95261B (en) T cell antigen receptor V region proteins and methods of preparation thereof
TW365809U (en) Disposable diaper
IL122584A0 (en) Diagnostic test meal and methods of use thereof
AU1521997A (en) Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus
EP0974842A4 (en) Reagent for examining agglutination of virus and kit for virus examination
IL118069A0 (en) Monoclonal antibody reactive to human cetp and assay method for human cetp
AU4274293A (en) Human monoclonal antibodies against cytomegalovirus and method for preparation thereof
ZA964981B (en) Isolation of naturally occurring isoflavonone and some clinical uses thereof
AU7201696A (en) Method of diagnosing crohn's disease
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus